Form 8-K - Current report:
SEC Accession No. 0001213900-25-055701
Filing Date
2025-06-18
Accepted
2025-06-18 17:15:08
Documents
18
Period of Report
2025-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246121-8k_180life.htm   iXBRL 8-K 74921
2 RELEASE AGREEMENT DATED JUNE 12, 2025, BY AND BETWEEN 180 LIFE SCIENCES CORP. AN ea024612101ex10-1_180life.htm EX-10.1 57808
3 180 LIFE SCIENCES CORP. 2025 OPTION INCENTIVE PLAN ea024612101ex10-2_180life.htm EX-10.2 96083
4 2025 OPTION INCENTIVE PLAN - FORM OF STOCK OPTION AGREEMENT (JUNE 2025 AWARDS) ea024612101ex10-3_180life.htm EX-10.3 67120
5 2022 OMNIBUS INCENTIVE PLAN - FORM OF NOTICE OF RESTRICTED STOCK GRANT AND RESTR ea024612101ex10-4_180life.htm EX-10.4 55967
6 AMENDED AND RESTATED EXECUTIVE CONSULTING AGREEMENT DATED JUNE 17, 2025, BY AND ea024612101ex10-6_180life.htm EX-10.6 109623
  Complete submission text file 0001213900-25-055701.txt   777576

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20250612.xsd EX-101.SCH 3798
8 XBRL DEFINITION FILE atnf-20250612_def.xml EX-101.DEF 26636
9 XBRL LABEL FILE atnf-20250612_lab.xml EX-101.LAB 36679
10 XBRL PRESENTATION FILE atnf-20250612_pre.xml EX-101.PRE 25260
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0246121-8k_180life_htm.xml XML 5820
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251057846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)